BDBM50059090 10-(4-Amino-butyl)-19-(2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carboxylic acid (2-hydroxy-1-hydroxymethyl-propyl)-amide::CHEMBL405598::SMS 201-995::octreotide
SMILES CC(O)[C@H](CO)NC(=O)[C@@H]1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)O)C(=O)N1
InChI Key InChIKey=DEQANNDTNATYII-LIXSYSMXSA-N
Data 95 KI
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 5 hits for monomerid = 50059090
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Novartis Pharma Research
Curated by PDSP Ki Database
Novartis Pharma Research
Curated by PDSP Ki Database
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Novartis Pharma Research
Curated by PDSP Ki Database
Novartis Pharma Research
Curated by PDSP Ki Database
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Novartis Pharma Research
Curated by PDSP Ki Database
Novartis Pharma Research
Curated by PDSP Ki Database
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Novartis Pharma Research
Curated by PDSP Ki Database
Novartis Pharma Research
Curated by PDSP Ki Database
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Novartis Pharma Research
Curated by PDSP Ki Database
Novartis Pharma Research
Curated by PDSP Ki Database